Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.